BioSpace News Archive

Biotage AB (Biotage), (NASDAQ OMX Stockholm: BIOT.ST) is pleased to announce its strategic collaboration with Shandong Yingsheng Biotechnology Co., Ltd. (Yingsheng). Yingsheng is mainly focused on independently researching, producing and selling in vitro diagnostic reagents and medical equipment, building a genetic detection platform and mass spectrometry detection platform around metabolomics and genetics.

Hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia are life-threatening hospital-related pulmonary infections that can particularly impact patients who are already dealing with severe underlying medical conditions.

Xofluza showed a significant preventive effect after a single oral dose. Only about 1.9% of patients who received Xofluza showed signs of the flu, compared to 13.6% of the placebo group.

Information exposed in the hacking includes financial data, Social Security numbers and medical information, Quest said.

As the American Society of Clinical Oncology Annual Meeting winds down, here’s a look at some of Monday’s top stories.

The add-on data showed that longer treatment with AR101 provided higher tolerance levels to peanut protein.

At the American Society of Clinical Oncology meeting in Chicago, Kite presented updated safety data from the ZUMA-1 trial that introduced a regimen of steroids to CAR-T patients who show early signs of neurologic events reduces the safety concerns associated the CAR-T treatment.

Patients were given Merck’s Keytruda (pembrolizumab) in combination with platinum chemotherapy, Keytruda by itself or chemotherapy by itself. The trial results found that the combination extended survival, and immunotherapy alone also worked well for some patients.

AstraZeneca underwent a restructuring earlier this year with an increased focus on oncology.

As a valued member of our BioSpace community, we are eager to hear more from you and other readers in 2019. We want to know your if you have ‘work-life balance’ with your job.